T cell receptor beta variable 14 (TRBV14)

T cell receptor beta variable 14 (TRBV14) encodes the variable region of the beta chain in alpha-beta T cell receptors, which are antigen-specific receptors expressed on T lymphocytes[1][4][6]. This region is essential for peptide-major histocompatibility complex (pMHC) recognition by T cells, a critical step in adaptive immunity and immune response to pathogens[1]. The TRBV14 gene is part of the broader T cell receptor beta (TRB) locus on chromosome 7, and diversity in the gene is generated through V-(D)-J rearrangement during thymic development[8]. Engagement of the TCR, including the TRBV14-encoded region, with antigen–MHC complexes leads to signal transduction via the CD3 complex and downstream activation of key signaling pathways required for T cell activation, proliferation, and effector responses[1]. TRBV14 is mainly expressed in T cells and is cell type-enriched in these populations[5]. Abnormalities in T cell receptor diversity and function, including TRBV family usage, have been implicated in immune disorders, cancer, and infection, but there are no specific drugs or direct interventions targeting TRBV14 itself[1][5][6].

Other names

TRBV14TCRBV14S1TCRBV16S1A1N1V_segment translation productTVB14 protein

null (No specific mechanism described for drugs targeting this exact TRBV segment. General TCR-based therapeutics use T cell receptor recognition for antigen targeting.)